Kathleen Almodova v. HHS - HPV, immune thrombocytopenic purpura (ITP) (2021)

Kathleen Almodova, as the parent and natural guardian of a minor named A.A., filed a petition on December 11, 2019, alleging that A.A. developed immune thrombocytopenic purpura (ITP) as a result of receiving the human papillomavirus (HPV), Tdap, and Menactra vaccines on March 23, 2018. The petitioner was unable to retain a hematologist expert to support causation-in-fact, which is a requirement for proving entitlement to compensation under the National Vaccine Injury Compensation Program.

Consequently, on December 23, 2021, the petitioner moved for a decision dismissing her case, stating that proceeding further would be unreasonable and would waste resources. The respondent did not object to the motion.

Special Master Nora Beth Dorsey reviewed the record and, in light of the petitioner's motion and the inability to meet the statutory requirements for entitlement, found that the petitioner was not entitled to compensation. The case was dismissed, and judgment was entered accordingly.

The public decision does not describe the specific symptoms, onset, or treatments related to A.A.'s alleged condition, nor does it name petitioner's counsel, respondent's counsel, or any experts. The decision was issued by Special Master Nora Beth Dorsey.